Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Supermag Advance
- Development stage
- Unknown
- Lead developer
- Penta Pharma
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Supermag Advance is a nutritional supplement developed by Penta Pharma, formulated with a synergistic combination of calcium, magnesium, and vitamin D. It is primarily indicated for the maintenance of bone health and the prevention of mineral deficiencies. Calcium serves as a fundamental structural element of the skeletal system, while vitamin D (typically provided as cholecalciferol) is essential for the active transport and absorption of calcium in the intestinal tract by activating the vitamin D receptor (VDR). Magnesium acts as a critical cofactor for over 300 enzymatic reactions, including those involved in bone mineralization, ATP production, and muscle contraction. By combining these three components, Supermag Advance supports optimal bone density and neuromuscular function, making it a common choice for individuals at risk of osteoporosis or those with dietary insufficiencies.
- Brand names
- Supermag Advance
- Other names
- Magnesium/Calcium/Vitamin D supplement
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Supermag Advance.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Supermag Advance.